A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

Completed · Phase 4

Conditions studied: Postmenopausal Osteoporosis

In brief

This study will investigate participant satisfaction (including compliance, preference, tolerability) with once-monthly Bonviva in women with post-menopausal osteoporosis or osteopenia transitioned from once-weekly alendronate or risedronate. The anticipated time on study treatment is 6 months, and the target sample size is 1776 individuals.

Key facts

Study ID

NCT02604836

Run by

Hoffmann-La Roche

People needed

1711

Starts

2004-06-01

Expected to finish

2006-04-01

Last updated by the study team

2016-11-02

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women who had been receiving once-weekly alendronate or risedronate for treatment or prevention of post-menopausal osteoporosis for greater than or equal to (>=) 3 months

You may not qualify if…

• Inability to stand or sit upright for >=60 minutes
• Hypersensitivity to bisphosphonates
• Inability to swallow a tablet whole
• Malignant disease diagnosed within previous 10 years (except resected basal cell cancer).

Where it is running

• Study site — Columbiana, Alabama, United States
• Study site — Huntsville, Alabama, United States
• Study site — Mobile, Alabama, United States
• Study site — Montgomery, Alabama, United States
• Study site — Chandler, Arizona, United States
• Study site — Gilbert, Arizona, United States
• Study site — Paradise Valley, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Tempe, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Carlisle, Arkansas, United States
• Study site — Jonesboro, Arkansas, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Pine Bluff, Arkansas, United States
• Study site — Rogers, Arkansas, United States
• Study site — Searcy, Arkansas, United States
• Study site — Sherwood, Arkansas, United States
• Study site — Anaheim, California, United States
• Study site — Beverly Hills, California, United States
• Study site — Laguna Hills, California, United States
• Study site — Mission Viejo, California, United States
• Study site — Palm Desert, California, United States
• Study site — Palo Alto, California, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.